Floatz logo

Azacitidine

AML/MDS

Newave Pharmaceutical IncSmall moleculePhase 1Dormant
CC
46/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
89/ 100

Competitive context

11 Active assets in the AML/MDS cohort.

Asset / SponsorPhaseRating
Midostaurin
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 2CCC
Decitabine
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 2CCC
lp-108
Newave Pharmaceutical Inc
Phase 1CC
Cyclophosphamide
St. Jude Children's Research Hospital
Phase 1CC
Mana 312
Mana Therapeutics
Phase 1CC

View all 13 →

Same molecule, other indications

Azacitidine is also rated in:

acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22)Dormant
BBB
Indicative ·
73 / 100
View asset →
acute erythroid leukemiaDormant
BB
Indicative ·
71 / 100
View asset →
non-small cell lung carcinomaDormant
BB
Indicative ·
71 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →